收稿日期: 2022-04-19
网络出版日期: 2023-11-22
基金资助
“十三五”国家科技重大专项(2018ZX10715004?002);广东省感染性疾病（结核病）临床医学研究中心(2020B1111170014)
Progress in the research of tuberculosis transmission
Received date: 2022-04-19
Online published: 2023-11-22
吴惠忠 , 胡锦兴 . 结核病传播研究进展[J]. 实用医学杂志, 2023 , 39(19) : 2424 -2427 . DOI: 10.3969/j.issn.1006-5725.2023.19.002
Eliminating the source of infection， cutting off the transmission route and protecting susceptible population are the keys to control the prevalence of tuberculosis. In this paper， the research progress of tuberculosis transmission is briefly summarized from the aspects of pathogen， infection sources， transmission vectors and routes of transmission， high?risk population and its protection and blocking。
| 1 | FURIN J，COX H，PAI M.Tuberculosis［J］.Lancet，2019，393（10181）：1642-1656. |
| 2 | PAI M， KASAEVA T， SWAMINATHAN S. Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery［J］. N Engl J Med，2022. |
| 3 | 王辉，马筱玲，钱渊，等. 主译.临床微生物学手册（第12版第1卷）［M］. 北京：中华医学电子音像出版社，2021：560-576. |
| 4 | SABIN S， HERBIG A， V?GENE ? J，et al. A seventeenth-century Mycobacterium tuberculosis genome supports a Neolithic emergence of the Mycobacterium tuberculosis complex［J］. Genome Biol，2020，21（1）：201. |
| 5 | FRESCHI L， VARGAS R， HUSAIN A，et al. Population structure， biogeography and transmissi- bility of Mycobacterium tuberculosis［J］. Nat Commun，2021，12（1）：6099. |
| 6 | ERNST J D. Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design［J］. Cell Host Microbe，2018，24（1）：34-42. |
| 7 | GYGLI S M， BORRELL S， TRAUNER A，et al. Antimicrobial resistance in Mycobacterium tuberculosis： mechanistic and evolutionary perspectives［J］. FEMS Microbiol Rev，2017，41（3）： 354-373. |
| 8 | MELSEW Y A， DOAN T N， GAMBHIR M，et al. Risk factors for infectiousness of patients with tuberculosis： a systematic review and meta-analysis［J］. Epidemiol Infect，2018，146（3）： 345-353. |
| 9 | URBANOWSKI M E， ORDONEZ A A， RUIZ-BEDOYA C A，et al. Cavitary tuberculosis： the gateway of disease transmission［J］.Lancet Infect Dis， 2020，20（6）：e117-e128. |
| 10 | O'SHEA M K， KOH G C， MUNANG M，et al. Time-to-detection in culture predicts risk of Mycobacterium tuberculosis transmission： a cohort study［J］. Clin Infect Dis，2014，59（2）： 177-185. |
| 11 | PATTERSON B， WOOD R. Is cough really necessary for TB transmission？［J］.Tuberculosis （Edinb），2019，117：31-35. |
| 12 | WURIE F B， LAWN S D， BOOTH H，et al. Bioaerosol production by patients with tuberculosis during normal tidal breathing： implications for transmission risk［J］. Thorax，2016，71（6）： 549-554. |
| 13 | DONALD P R， DIACON A H， LANGE C，et al. Droplets， dust and guinea pigs： an historical review of tuberculosis transmission research，1878-1940［J］.Int J Tuberc Lung Dis，2018，22（9）： 972-982. |
| 14 | STITI M， CASTANET G， CORBE A，et al. Transition from saliva droplets to solid aerosols in the context of COVID-19 spreading［J］.Environ Res，2022204（Pt B）：112072. |
| 15 | FENNELLY K P. Particle sizes of infectious aerosols： implications for infection control［J］. Lancet Respir Med，2020，8（9）：914-924. |
| 16 | SCHIJVEN J， VERMEULEN L C， SWART A，et al. Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing， Speaking， Singing， Coughing， and Sneezing［J］. Environ Health Perspect，2021，129（4）：47002. |
| 17 | DINKELE R， GESSNER S， MCKERRY A，et al. Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols［J］.PLoS Pathog，2021，17（2）： e1009262. |
| 18 | PATTERSON B， WOOD R. Is cough really necessary for TB transmission？［J］Tuberculosis （Edinb），2019，117：31-35. |
| 19 | JONES-LóPEZ E C， ACU?A-VILLAORDU?A C， SSEBIDANDI M，et al. Cough Aerosols of Mycobacterium tuberculosis in the Prediction of Incident Tuberculosis Disease in Household Contacts［J］. Clin Infect Dis，2016，63（1）：10-20. |
| 20 | MARTINEZ L， VERMA R， CRODA J，et al. Detection， survival and infectious potential of Mycobacterium tuberculosis in the environment： a review of the evidence and epidemiological implications［J］.Eur Respir J，2019，53（6）：1802302. |
| 21 | ZUMLA A， YEBOAH-MANU D， MICHEL A L，et al. Zoonotic tuberculosis-a call for an open One Health debate［J］. Lancet Infect Dis，2020，20（6）：642-644. |
| 22 | DEAN A S， FORCELLA S， OLEA-POPELKA F，et al. A roadmap for zoonotic tuberculosis： a One Health approach to ending tuberculosis［J］. Lancet Infect Dis，2018，18（2）：137-138. |
| 23 | BUSS B F， KEYSER-METOBO A， ROTHER J，et al. Possible Airborne Person-to-Person Transmission of Mycobacterium bovis - Nebraska 2014-2015［J］. MMWR Morb Mortal Wkly Rep，2016， 65（8）：197-201. |
| 24 | BERG S， SMITH N H. Why doesn't bovine tuberculosis transmit between humans？［J］. Trends Microbiol，2014，22（10）：552-553. |
| 25 | HOUBEN R M， DODD P J. The Global Burden of Latent Tuberculosis Infection： A Re-estimation Using Mathematical Modelling［J］. PLoS Med，2016，13（10）：e1002152. |
| 26 | CAMPBELL J R， WINTERS N， MENZIES D. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result： systematic review and meta-analysis［J］. BMJ，2020，368：m549. |
| 27 | BJORN-MORTENSEN K， LILLEBAEK T， KOCH A，et al. Extent of transmission captured by contact tracing in a tuberculosis high endemic setting［J］. Eur Respir J，2017，49（3）：1601851. |
| 28 | ACU?A-VILLAORDU?A C， JONES-LóPEZ E C， FREGONA G，et al. Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease［J］. Eur Respir J，2018， 51（1）：1701578. |
| 29 | MARTINEZ L， CORDS O， HORSBURGH C R，et al. The risk of tuberculosis in children after close exposure： a systematic review and individual-participant meta-analysis［J］. Lancet，2020， 395（10228）：973-984. |
| 30 | LUZZATI R， MIGLIORI G B， ZIGNOL M，et al. Children under 5?years are at risk for tuberculosis after occasional contact with highly contagious patients： outbreak from a smear-positive healthcare worker［J］. Eur Respir J，2017，50（5）：1701414. |
| 31 | MAYNARD-SMITH L， BROWN C S， HARRIS R J，et al. Effectiveness and outcomes of air travel- related TB incident follow-up： a systematic review［J］. Eur Respir J，2021，57（5）：2000013. |
| 32 | SCRIBA T J， FIORE-GARTLAND A， PENN-NICHOLSON A，et al. Biomarker-guided tuberculosis preventive therapy （CORTIS）： a randomised controlled trial［J］. Lancet Infect Dis，2021， 21（3）：354-365. |
| 33 | SHAH M， DORMAN S E. Latent Tuberculosis Infection［J］. N Engl J Med，2021，385（24）：2271-2280. |
| 34 | KNIGHT G M， MCQUAID C F， DODD P J，et al. Global burden of latent multidrug-resistant tuberculosis：trends and estimates based on mathematical modelling［J］. Lancet Infect Dis， 2019，19（8）：903-912. |
/
| 〈 |
|
〉 |